Investigation Into the Automated Drainage of Recurrent Effusions From the Pleural Space in Thoracic Malignancy. (ADEPT)
Sponsor: Sequana Medical N.V.
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Sequana Medical N.V.
More terminations from Sequana Medical N.V.
Other Pleural Effusion trials with similar outcome
Listed as NCT01952327, this NA trial focuses on Pleural Effusion and remains terminated or withdrawn. Sponsored by Sequana Medical N.V., it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Nov 2019 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Nov 2019 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sequana Medical N.V.
For direct contact, visit the study record on ClinicalTrials.gov .